CaPtivatϵ Pharmaceuticals LLC is a privately-owned small biotechnology company focused on developing its proprietary calcium phosphate nanoparticle vaccine adjuvant and antigen delivery platform, CaPtivantTM (formarly called "BioVant") for applications in human or veterinary vaccines. The technology enables formulation of vaccines for parenteral or mucosal administration and for prophylactic or therapeutic use.
While continuing to develop our own vaccine programs to address significant public health needs, we make CaP nanoparticle technology and formulation services available to interested partners who may be searching for a safe and effective antigen delivery system to develop novel vaccine formulations against many life threatening diseases.
